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http://www.wjso.com/content/12/1/374CASE REPORT Open AccessPrimitive neuroectodermal tumor (PNET) of the
lung in an adult woman
Mariam Gachechiladze1*†, Josef Škarda1*†, Maha Ibrahim2, Tomáš Tichý1, Patrik Flodr1, Pavla Latálová1,
Jiří Ehrmann1, Radek Trojanec1 and Zdenek Kolář1Abstract
Primary primitive neuroectodermal tumors (PNETs) are extremely rare in the lung and especially in adult women.
We describe a case of PNET of the lung with aggressive behavior in 31-year-old woman. Diagnosis was based on
histopathological and immunohistochemical studies, and confirmed by molecular genetic analysis of chromosome
rearrangements in the EWSR1 gene region. Clinical follow-up, post-mortem findings, and differential diagnosis are
also discussed.
Keywords: Primitive neuroectodermal tumor, Ewing’s sarcoma, Lung, Differential diagnosisBackground
Primitive neuroectodermal tumors (PNETs) are small-
blue-round-cell malignancies, predominantly arising in
the soft tissues or bones in children and young adults
[1]. PNETs belong to the Ewing’s sarcoma family of
tumors, based on shared chromosomal translocation at
EWSR1 (Ewing sarcoma breakpoint region 1). Primary
PNETs of the lung are extremely rare, with fewer than
20 cases having been described in English literature to
date. Most of these are adolescent or young adult
patients, with a male predominance [2-13]. In this case
report, we describe a PNET of lung in an adult woman,
having a rapid progression of the disease and lethal
outcome.
Case presentation
A 31-year-old woman presented with a 10-month history
of right hemithoracic pain and persistent cough, with rela-
tive improvement during the day and relative worsening at
night. She also reported a weight loss of approximately
11 kg. Computed tomography (CT) and positron emission
tomography (PET) imaging of the thorax revealed non-
homogeneous opacities and increased accumulation of
glucose in the right pleural cavity. Right pleural deposits,* Correspondence: marjammg@gmail.com; jojos@email.cz
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article, unless otherwise stated.found during examination, suggested the presence of
viable tumor masses. Directed transparietal biopsy, taken
from the glucose accumulation sites seen on the PET scan,
was performed.
Histopathological examination of the biopsy specimens
revealed highly cellular neoplastic tissue. The tumor cells
were discohesive, showed scant basophilic cytoplasm, and
ovoid rather than polygonal nuclei, fine granular chromatin
texture, and marked nucleoli. Some of the nuclei were
hyperchromatic. There were no evidence of mitotic or
apoptotic activity. No obvious signs of necrosis were
present, and the stromal tissue adjacent to the tumor
was characterized by low cellularity. In some areas, small
Homer-Wright rosette-like structures were present. Over-
all, morphological characteristics were consistent with
small-blue-round-cell neoplasm (Figure 1a, b ,c).
A range of immunohistochemical markers were employed
for final diagnosis (Table 1), including CD4, CD8, CD10,
CD15, CD20, CD34, leukocyte common antigen (CD45),
CD56, CD99, cytokeratin 7 (CK7), vimentin, thyroid tran-
scription factor (TTF), synaptophysin, chromogranin, anti-
cytokeratin cocktail, High Molecular weight cytokeratin,,
calretinin, h-caldesmon, smooth muscle actin (SMA) and
mesothelial cell marker (antibody clone: HBME-1). Detailed
characteristics and dilutions of antibodies are provided
in Additional file 1: Table S1. Immunohistochemical study
showed Strong positivity for CD99 (Figure 1d). The
neoplastic cells were also focally positive for CD56 and
weekly positive for Vimentin (Figure 1e, f ). ExpressionCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Biopsy specimen from primitive neuroectodermal tumor (PNET) of the lung. (a) Areas of highly cellular neoplastic tissue
(H&E, magnification × 40), (b) discohesive growth of small, blue, round to oval cells, characteristic of pulmonary PNET (H&E, magnification × 200).
(c) Characteristic scant, basophilic cytoplasm, ovoid or polygonal nuclei, fine granular chromatin texture and marked nucleoli. Some nuclei were
hyperchromatic. H&E, magnification × 400. d) CD99 membranous expression, characteristic of PNET (magnification × 100). and expression of (e) CD56
(magnification × 100) and (f) vimentin (magnification × 100). (g, h) Fluorescent in situ hybridization of EWSR1 gene: fusion signals: yellow or red/green
double spot indicates intact EWSR1, separate green and red signals indicate translocation. Magnification (g) × 600, (h) × 1000).
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negative. Proliferative activity, detected by Ki-67 index,
was estimated as 5 to 10%. Immunophenotype was
characteristic for PNET of the lung.
Chromosome rearrangement in the EWSR1 gene was
detected by fluorescent in situ hybridization assay (FISH)
to confirm the diagnosis. The results of FISH analysis
showed translocation of EWSR1 in 30% of the tumor cells
(Figure 1g, h). More detailed description of molecular
analysis in provided in Additional file 1: S2.
Diagnosis was followed by two series of chemotherapy
(doxorubicin, cyclophosphamide and vincristine) for 2 days.
After 1 month, secondary anemia developed. The patient
was treated with hemosubstitution, but her health deterio-
rated and she died. Post-mortem examination revealed a
tumor in the right lung, 210 × 115 × 60 mm in size. The
cut surface of the tumor was pinkish colored and areas of
hemorrhage were present. Post-mortem and subsequenthistopathological examination showed generalized PNET,
(Additional file 1: Figure S1), with tumor spread to the
mediastinal lymph nodes and subhepatic area. Acute
catarrhal purulent bronchopneumonia was present in the
left lung. The cause of death was given as cardiorespiratory
failure.
Discussion
PNETs are highly aggressive, usually lethal neoplasms. Al-
though the morphological and immunohistochemical
features of pulmonary PNET are not different from its
counterparts of other origin, special diagnostic consid-
erations of other tumors with small, blue, round cell
morphology and primarily small cell carcinoma of the
lung is necessary. Small cell carcinomas usually present
at older ages, and usually with a history of smoking, yet
they and PNET may exhibit similar histological features.
Some PNETs may even show reactivity for cytokeratin and
Table 1 Differential diagnostic markers of small-blue- round-cell tumors in lung
IHC markers CD99 CD56 Vim TTF Syn Chr CD34 LCA (CD45) CD10 CD15 CK7 AE1/AE3 CK(HMW) Calret h-Cal Desmin SMA HBME-1
Tumor types
PNET ++ +/- + − +/- − − − − − − +/- − − − − − −
Desmoplastic small round cell tumor
of lung
− − ++ − − − − − − − − ++ − − − − − −
Small cell carcinoma of the lung − + - ++ + + − − − − − ++ − + − − − −
Lung carcinoid − − − + ++ ++ − − − − − ++ − − − − − −
Metastasis of small cell carcinomas
of other origin
− +/- − + − − − − − − + + + − − − − −
Pulmonary rhabdomyosarcoma − − − − − − − − − − − − − − + + − −
NHL +/- − − − − − − ++ + + − − − − − − − −
Calret, calretinin; Chr, chromogranin; CK7, cytokeratin 7; CK(HMW), high molecular weight cytokeratin; HBME-1 – mesothelial cell marker; h-Cal, h-caldesmon; IHC, immunohistochemistry; LCA, leukocyte common
antigen; NHL, non-Hodgkin’s lymphoma; PNET, primitive neoroectodermal tumor; SMA, smooth muscle actin; Syn, Synaphtophysin; TTF, thyroid transcription factor; Vim, vimentin.
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histochemical markers, including chromogranin and
TTF-1 to support a diagnosis of small cell carcinoma,
and CD99, vimentin, or FLI1 for PNET should be used
for the differential diagnosis. Lung carcinoids share a
similar morphology to PNET and form rosettes. However,
the detection of chromogranin, synaphtopysin, and neuron
specific enolase is necessary to confirm the diagnosis of
lung carcinoid. In addition, differential diagnosis is neces-
sary to distinguish PNET from metastasis of small cell
carcinomas of other origin. Another important diagnostic
consideration for both children and adult patients is
pulmonary rhabdomyosarcoma, which is also a rare tumor
and belongs to the group of small,-blue,-round-cell tumors.
Muscle-specific markers such as desmin, myogenin, or
myo-D1, characteristic of rhabdomyosarcoma, should
be included in the immunohistochemical study [10].
Lymphoblastic lymphoma and the leukemia group of
tumors are also an important diagnostic consideration, as
they can be positive for CD99 and negative for epithelial
markers. Precursor B-cell lymphoblastic lymphoma is an
especially important mimicker of PNET. Like PNET, the
malignant cells are small and uniform and have a
diffusely infiltrative growth pattern, and they can even
form rosette-like structures. Immunohistochemically,
precursor B-cell lymphoblastic lymphoma is positive for
CD99, and often nonreactive or only focally positive for
conventional lymphoma markers such as LCA, CD20, and
CD3. Immunopositivity for CD45, CD43, and CD79a are
useful for separating lymphoblastic lymphoma/leukemia
from PNET [14]. Finally, to confirm the diagnosis of
PNET, it is crucial to detect pass break or amplification of
EWSR1 [15]. However, because of the rarity of primary
pulmonary PNETs, it is also important to exclude the
possibility of metastasis from a bone or soft tissue primary
to the lung. Detailed examination by clinical and radio-
logical means should be performed to rule out metastatic
tumor from an extrapulmonary primary site.
Conclusion
Pulmonary PNET should be considered in the differen-
tial diagnosis of thoracic tumors, regardless of the age
and sex of the patient. Although not specific, CD99 and
vimentin are important immunohistochemical markers
for diagnosis of PNET. However, a wider range of
antibodies should be employed in order to exclude other
diagnostic possibilities. Detection of EWSR1 gene trans-
location or amplification is the most reliable marker of
PNET, including those of pulmonary origin.
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